Syschem India Ltd. Announces Unaudited Financial Results for Q3 2025, Approves Expansion of Existing Plant Units

Syschem India Ltd. has announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company's revenue from operations stands at 16,164.37 INR, with a profit before tax of 918.60 INR. The Board of Directors also approved the expansion of existing plant units, including the addition of a new manufacturing unit for Amoxicillin and Ampicillin, and further expansion of the existing CDF unit. The expansion is expected to significantly enhance the company's manufacturing capacity, operational efficiency, and environmental management capabilities.